BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19571319)

  • 1. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
    Ramirez P; Rettig MP; Uy GL; Deych E; Holt MS; Ritchey JK; DiPersio JF
    Blood; 2009 Aug; 114(7):1340-3. PubMed ID: 19571319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis.
    Zhang J; Ren X; Shi W; Wang S; Chen H; Zhang B; Wang Z; Zhou Y; Chen L; Zhang R; Lv Y; Zhou J; Nan X; He L; Yue W; Li Y; Pei X
    Blood; 2014 Jan; 123(3):428-41. PubMed ID: 24196072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
    Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
    Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 and mobilization of hematopoietic precursors.
    Rettig MP; Ramirez P; Nervi B; DiPersio JF
    Methods Enzymol; 2009; 460():57-90. PubMed ID: 19446720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100.
    Alt C; Yuan S; Wu F; Stankovich B; Calaoagan J; Schopies S; Wu JY; Shen J; Schneider D; Zhu Y; Zhao XY; Lippow SM; Bauzon M
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1475-1485. PubMed ID: 31163266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent blockade of alpha4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization.
    Bonig H; Watts KL; Chang KH; Kiem HP; Papayannopoulou T
    Stem Cells; 2009 Apr; 27(4):836-7. PubMed ID: 19350684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice.
    Chen C; Cao J; Song X; Zeng L; Li Z; Li Y; Xu K
    Int J Hematol; 2013 Jan; 97(1):50-7. PubMed ID: 23224606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior long-term repopulating capacity of G-CSF+plerixafor-mobilized blood: implications for stem cell gene therapy by studies in the Hbb(th-3) mouse model.
    Psatha N; Sgouramali E; Gkountis A; Siametis A; Baliakas P; Constantinou V; Athanasiou E; Arsenakis M; Anagnostopoulos A; Papayannopoulou T; Stamatoyannopoulos G; Yannaki E
    Hum Gene Ther Methods; 2014 Dec; 25(6):317-27. PubMed ID: 25333506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.
    Christopher MJ; Liu F; Hilton MJ; Long F; Link DC
    Blood; 2009 Aug; 114(7):1331-9. PubMed ID: 19141863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
    Mohty M; Ho AD
    Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.
    Karpova D; Rettig MP; Ritchey J; Cancilla D; Christ S; Gehrs L; Chendamarai E; Evbuomwan MO; Holt M; Zhang J; Abou-Ezzi G; Celik H; Wiercinska E; Yang W; Gao F; Eissenberg LG; Heier RF; Arnett SD; Meyers MJ; Prinsen MJ; Griggs DW; Trumpp A; Ruminski PG; Morrow DM; Bonig HB; Link DC; DiPersio JF
    J Clin Invest; 2019 May; 129(7):2745-2759. PubMed ID: 31085833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
    Pusic I; DiPersio JF
    Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights.
    Albanese P; Caruelle D; Frescaline G; Delbé J; Petit-Cocault L; Huet E; Charnaux N; Uzan G; Papy-Garcia D; Courty J
    Exp Hematol; 2009 Sep; 37(9):1072-83. PubMed ID: 19539688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.
    Di Giacomo F; Lewandowski D; Cabannes E; Nancy-Portebois V; Petitou M; Fichelson S; Romeo PH
    Haematologica; 2012 Apr; 97(4):491-9. PubMed ID: 22180429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced
    Lidonnici MR; Aprile A; Frittoli MC; Mandelli G; Paleari Y; Spinelli A; Gentner B; Zambelli M; Parisi C; Bellio L; Cassinerio E; Zanaboni L; Cappellini MD; Ciceri F; Marktel S; Ferrari G
    Haematologica; 2017 Apr; 102(4):e120-e124. PubMed ID: 28034992
    [No Abstract]   [Full Text] [Related]  

  • 20. A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study.
    Fruehauf S; Veldwijk MR; Seeger T; Schubert M; Laufs S; Topaly J; Wuchter P; Dillmann F; Eckstein V; Wenz F; Goldschmidt H; Ho AD; Calandra G
    Cytotherapy; 2009; 11(8):992-1001. PubMed ID: 19929463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.